Granules India Ltd
GRANULES
Company Profile
Business description
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.
Contact
3rd Block
2nd Floor, My Home Hub
Madhapur
HyderabadTG500081
INDT: +91 4069043500
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
6,524
Stocks News & Analysis
stocks
Megatrend Investing 2025 and beyond: ASX players to capitalise on the clean energy transition
Find out how you can benefit from global megatrends.
stocks
DeepSeek revelation hits US chip stocks, ASX data centres and uranium
Shockwaves from Monday's AI stock panic in the US were largely confined to two ASX industries.
video
What does a weak Aussie dollar mean for investors?
Morningstar Investment Management's Chief Investment Officer for Asia Pacific weighs in on the weak Aussie dollar and what this could mean for investors.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,789.70 | 43.80 | 0.50% |
| CAC 40 | 7,950.17 | 8.53 | 0.11% |
| DAX 40 | 21,732.05 | 4.85 | 0.02% |
| Dow JONES (US) | 44,544.66 | 337.47 | -0.75% |
| FTSE 100 | 8,673.96 | 27.08 | 0.31% |
| HKSE | 20,225.11 | 27.34 | 0.14% |
| NASDAQ | 19,627.44 | 54.31 | -0.28% |
| Nikkei 225 | 39,572.49 | 58.52 | 0.15% |
| NZX 50 Index | 12,995.01 | 66.63 | 0.52% |
| S&P 500 | 6,040.53 | 30.64 | -0.50% |
| S&P/ASX 200 | 8,532.30 | 38.60 | 0.45% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |